Drug Injury Lawyer

Drug AND PERSONAL INJURY

The pharmaceutical industry is hugely profitable. Drug manufacturing giants aggressively market their products with their sights set almost exclusively on profits while they downplay or hide the health risks associated with their "wonder drugs." All too often, the Food and Drug Administration (FDA) must request stricter warning labels, only to pull the drug off the market months later. By the time these dangerous medications are recalled case reports of drug injury and death have accumulated and people may not know where to turn.

Our drug recall attorneys handle drug recall and pharmaceutical cases because we think the public deserves compensation for drug companies' carelessness. Below are links to all you need to know about drug recalls and medications that have made headlines with their frightening side effects, which include: pulmonary hypertension, hemorrhagic strokes, kidney damage, kidney failure, and more.

If you have been injured, contact the drug injury attorneys at Ferrer, Poirot & Wansbrough. Complete a FREE Consultation Form online or call us today!

ACE Inhibitors

Certain blood pressure medications, commonly known as ACE (angiotensin-converting enzyme) inhibitors, have recently been linked to severe and life-threatening birth defects in children whose mothers took the drugs during their first trimester of pregnancy. [read more]

Accutane®

Isotretinoin is an oral medicine prescribed for severe nodular acne. Side effects are seizures, stroke, permanent loss of sight, birth defects, and severe depression. [read more]

Baycol®

Baycol was prescribed to help lower cholesterol, but it came with the risk of kidney damage or failure. It was taken off the market in 2001. [read more]

Bextra®

The most recent addition to the COX-2 class of drugs, Bextra was approved by the FDA in 2001 and is prescribed mainly as a pain reliever for sufferers of arthritis and other painful conditions. However, patients given Bextra after heart bypass surgery showed triple the risk of serious cardiovascular events. [read more]

Celebrex®

Celebrex has become one of the most prescribed drugs in its class, primarily as a pain reliever for arthritis and other conditions. However, in December 2004, the safety of this popular drug came into question when the National Cancer Institute halted a Celebrex trial because of an increased risk of cardiovascular events. [read more]

Crestor®

Crestor (rosuvastatin) is a cholesterol-lowering medication in the statin class that was approved by the FDA on August 13, 2003. In its first five months on the market, it had attributed to three cases of kidney failure or muscle damage in the United States. Read more about this dangerous drug. [read more]

Fosamax®

Fosamax® (alendronate), a medicine that has been on the market for almost 10 years, has been linked to osteonecrosis of the jaw (ONJ). Otherwise known as "dead jaw," osteonecrosis is a severe condition in which the jaw dies and is unable to regenerate, eventually leading to extreme pain and exposed bone in the mouth. [read more]

Gynecare Intergel®

In 2001, the makers of Gynecare Intergel™, the first liquid scar-prevention surgical solution to be used in open pelvic surgery, encountered many problems in their quest for FDA approval. The FDA initially rejected the product, citing unacceptable risks. [read more]

Hormone Replacement Therapy (HRT)

HRT's estrogen-progestin drug therapy now has been shown to significantly increase the risks for strokes, breast cancer, heart attacks, pulmonary embolism, and more. Read more about this dangerous drug. [read more]

Ortho Evra®

Ortho Evra is a birth control patch that is applied to the arms, torso, abdomen, or buttocks once a week and offers the same effectiveness as birth control pills with even greater simplicity. It turns out, however, that women using Ortho Evra are at an increased risk for fatal blood clots compared to women taking birth control pills. [read more]

Paxil®

On September 27, 2005, the Food and Drug Administration (FDA) and GlaxoSmithKline notified healthcare professionals of changes to the Pregnancy/PRECAUTIONS section of the Prescribing Information for Paxil to describe the results of a study of major congenital malformations, which are physical body or organ malformations existing at birth. [read more]

PPH

Primary Pulmonary Hypertension (PPH) is a rare, progressive disorder characterized by high blood pressure (hypertension) of the main artery of the lungs (pulmonary artery). The pulmonary artery is a blood vessel carrying oxygen-poor blood from the right ventricle (one of the heart's pumping chambers) to the lungs. In the lungs, the blood picks up oxygen, then flows to the heart's left side, where the left ventricle pumps it to the rest of the body through the aorta. [read more]

Stevens-Johnson Syndrome (SJS)

Stevens-Johnson Syndrome (SJS) is a condition described by resulting severe skin reactions that include rashes and blisters that can progress to third-degree burn-like intensity. SJS may result from many causes, though adverse drug reactions are often reported in conjunction with the condition. Pfizer, Inc. removed Bextra® from the market in April 2005 for this reason. [read more]

Trasylol®

Trasylol®, a medication frequently used during heart surgery to control bleeding, has been found to double the risk of kidney failure in patients. An estimated 10,000 people are forced to undergo dialysis each year after receiving the drug, which was approved by the FDA in 1993. Trasylol, generically known as aprotinin, is manufactured by Bayer AG and had projected sales estimates of more than $600 million in 2006. [read more]

Viagra®, Cialis®, Levitra® Linked to Blindness

On July 7, 2005, the FDA released the following news alert: A small number of men have lost eyesight in one eye some time after taking Viagra, Cialis, or Levitra. This type of vision loss is called non-arteritic anterior ischemic optic neuropathy (NAION). NAION causes a sudden loss of eyesight because blood flow is blocked to the optic nerve. [read more]

Vioxx®

Vioxx (rofecoxib) is a non-steroidal anti-inflammatory drug (NSAID) approved by the FDA in 1999 and prescribed to help ease acute pains associated with osteoarthritis, rheumatoid arthritis, menstrual cramps, migraines, and other painful conditions. [read more]

• Auto Accident
• Birth Injury
• Defective Medical Device
• Drug Injuries
• Environmental
• Medical Malpractice
• Motorcycle Accident
• Nursing Home Abuse
• Truck Accident